Drug intelligence / Profile preview

simvastatin cubosomal nanoparticles

Development stage
Unknown
Lead developer
Assiut University
Modality
Small Molecules, Nanoparticles → Drug Delivery Systems
Administration
Topical
01

Overview

Simvastatin is a small molecule HMG-CoA reductase inhibitor traditionally used to treat hyperlipidemia. Assiut University is investigating a novel topical formulation of simvastatin, utilizing cubosomal nanoparticles, for the treatment of alopecia areata. This autoimmune condition is characterized by T-cell mediated destruction of hair follicles; simvastatin is hypothesized to treat this by exerting pleiotropic immunomodulatory effects, such as inhibiting T-cell activation and reducing inflammatory cytokine levels. The drug is being evaluated in a Phase 4 clinical trial, both as a standalone topical treatment and in combination with fractional CO2 laser-assisted delivery, to compare its efficacy against conventional topical corticosteroids like mometasone furoate.

Other names
topical simvastatinsimvastatin cubosomes
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on simvastatin cubosomal nanoparticles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on simvastatin cubosomal nanoparticles.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call